June 8, 2020 — Marksans Pharma Ltd., India has voluntarily recalled extended-release metformin after FDA tests found high levels of a cancer-causing chemical.
The recall involves the diabetes drug metformin ER (500-mg) — Lot# XP9004 — in 100 count bottles with NDC code 49483-623-01 and expiration date 12/2020. It was distributed by Time-Cap Labs, Inc.
The FDA is recommending that patients keep taking their metformin, even if it has been recalled, until they can talk to their doctor about prescribing a replacement.
NDMA has been detected in other types of metformin ER, including medicines distibuted by Teva Pharmaceuticals, Amneal Pharmaceuticals, Apotex Corp., and other drug-makers.
Lawsuits have been filed by people who developed cancer after long-term exposure to NDMA in other medicines, such as Zantac® heartburn drugs and Valsartan blood pressure drugs.
NDMA is a chemical that is believed to cause cancer in humans. A growing number of lawsuits allege that NDMA exposure can cause breast cancer, bladder cancer, stomach cancer, and more.
The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs' law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm's reputation for providing personal attention to each and every client we represent.
